Our innovative collaborations with Hackensack Meridian Health and Quest Diagnostics, as well as the relationships we’re building through own MSK Cancer Alliance, are helping us improve the quality of cancer care for people across the United States and all over the world.
Memorial Sloan Kettering Cancer Center (MSK) and New York Cancer & Blood Specialists (NYCBS), one of the fastest-growing community oncology practices in the nation, today announced plans to open a 39,000 sq ft facility in Brooklyn, New York, in early 2023.
Memorial Sloan Kettering and Hackensack Meridian Health have formed a strategic partnership to rewrite the future of cancer care.
MSK Direct connects employer, union, and other health benefits sponsors with MSK’s world-class cancer solutions. Learn more.
The MSK Cancer Alliance is an initiative designed to help community providers improve the quality of their cancer care.
Memorial Sloan Kettering and Quest Diagnostics have a joint collaboration that will utilize MSK’s clinical and research insights into gene mutations associated with solid tumors.
Foundation Medicine and Memorial Sloan Kettering have partnered to bring together clinical, genomic and computational expertise to advance patient care in hematologic cancers.
Memorial Sloan Kettering is partnering with two other New York City health institutions to offer proton therapy in upper Manhattan.